GSK adopts Lyell’s services to improve T cell ‘fitness’ 10-Oct-2019 By Vassia Barba GSK taps Lyell’s technology to delay ‘exhaustion’ of T cells and will explore creating a new platform to develop cell and gene therapies for rare cancers.